Novo Nordisk Is Already Working on Wegovy's Successor -- Time to Buy?

Some pharmaceutical products have become massively popular in the past few years. The class of vaccines and drugs that help prevent and treat COVID-19 is a good example. These allowed us to contain the pandemic, so their fame is well deserved. Another category of drugs has been making plenty of noise lately: anti-obesity medicines.Perhaps the most famous is Wegovy, marketed by Novo Nordisk (NVO -1.64%). The Denmark-based drugmaker is a leader in this niche. Though Wegovy still has a long and bright future a ...